Curative Biotechnology Inc (CUBT)

[MarkDaShark]

I've been reading more about the rat trials with IMT504, I'm definitely holding until at least the middle of the phase 1 trial, and will decide based on trial sponsors where to go from there. This drug in every study says it's extremely safe, so I expect the trial to finish, though I'm currently unconvinced atm whether it'll be a positive or negative result (need to do more analysis of the rat trials and preclincal human trials, as there is a lot of papers to read), but what I am positive in is Paul to negotiate the deals to get it to a well deserving trial.

This will accumulate to 30 cents to a dollar by end of Q1 next year (prolly sooner), and will flux between that until the trial starts (unless its a high quality trial from a well recognized hospital or university, then it might be over a dollar).

One thing I am worried about is the restructuring of the stock to add class B+C preferred stock, which indicates to me that there will be dilution of preferred stock (not float thankfully), which could harm the price, but considering the smaller ss atm, it should be able to handle it, considering they will only need to raise 10-30 mil in funds (prv application + running trials).